Renova to begin Phase III of RT-100 in heart failure

Renova Therapeutics (San Diego, Calif.) said it will start this quarter the Phase III FLOURISH trial of gene therapy RT-100 (Ad5.hAC6) to

Read the full 222 word article

User Sign In